Analytical Evaluations of Limitations of Phenobarbital as 1 st -Line Therapy in Acute Neonatal Seizures: Comparison Assessment with Newer Antiepileptics
Background : Acute neonatal seizures are among the most common neurological emergencies during the neonatal period and are associated with increased mortality and long-term neurodevelopmental impairment. Phenobarbital has remained the conventional first-line antiseizure medication because of its rapid onset of acti...